Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
936.35
-6.20 (-0.66%)
< Home < Back

Cadila Healthcare reports 23% rise in Q1 consolidated net profit

Date: 31-07-2014

Cadila Healthcare has reported results for first quarter ended June 30, 2014.

The company’s net profit has decreased by 42.01% at Rs 197.29 crore as compared to Rs 340.22 crore for the quarter ended June 30, 2013. Its total income has decreased by 1.61% to Rs 1129.13 crore for the quarter under review from Rs 1147.64 crore for the corresponding quarter of the previous year.

On the consolidated basis, the company has reported 23.15% rise in its net profit after taxes, minority interest and share of profit / (loss) of associates at Rs 240.21 crore for the quarter as compared to Rs 195.06 crore for the same quarter in the previous year. Total income has increased by 24.91% at Rs 2060.50 crore for quarter under review as compared to Rs 1649.58 crore for the quarter ended June 30, 2013.